BSE filing, NSE: CAPRO. Summary written from the filing by ALFA Finder's alert engine.
Caprolactam Chemicals Ltd: key numbers
- Share price
- ₹50.00
- Market cap
- ₹23.00 Cr
- Revenue (annual)
- ₹10.56 Cr
- Net profit (annual)
- ₹1.76 Cr
- P/E (TTM)
- 56.1×Sector 34.1×
- Promoter holding
- 54.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Caprolactam Chemicals Ltd
All →Caprolactam Chemicals Board Meeting Date
Caprolactam Chemicals will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window is closed from 1 October 2026.
Caprolactam Chemicals Other Announcement
Caprolactam Chemicals Ltd has filed its quarterly shareholding pattern report under Regulation 31(1)(b) of the SEBI LODR Regulations for the period ended 30 September 2026.
Caprolactam Chemicals Annual General Meeting
Caprolactam Chemicals Ltd. held its 37th Annual General Meeting on September 28, 2026. Shareholders considered routine items, including financial statements and the appointment of statutory auditors.
Caprolactam Chemicals Other Announcement
Caprolactam Chemicals Ltd. has appointed M/s. Raman S. Shah & Co. as the company's Statutory Auditor for a term of 60 months.
Caprolactam Chemicals Management Change
Caprolactam Chemicals internal auditor Shrey Pandey & Associates resigned effective 10 Sept 2026. Parth Patel D & Associates was appointed as the new internal auditor for FY 2026-27.
Caprolactam Chemicals Annual General Meeting
Caprolactam Chemicals Ltd. has issued a notice for its 37th Annual General Meeting to be held on September 28, 2026, through video conference.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.